Form 4: USANA Health Sciences CFO Receives Restricted Stock Units
SEC Form 4 Filing
G. Doug Iiekking, CFO of USANA Health Sciences, was granted 29,877 restricted stock units on February 27, 2025, according to a Form 4 filing.
Summary
- G. Doug Iiekking, the Chief Financial Officer of USANA Health Sciences Inc., received 29,877 restricted stock units on February 27, 2025.
- These restricted stock units represent a contingent right to receive one share of USNA common stock each.
- The restricted stock units vest at a rate of 25% on each subsequent February 27th.
Sentiment
Score: 7
Explanation: The document indicates a standard executive compensation practice, suggesting stability and alignment of interests. It's a neutral to slightly positive event.
Positives
- The grant of restricted stock units aligns the CFO's interests with those of the shareholders, incentivizing him to improve the company's performance.
Future Outlook
The vesting schedule suggests a long-term commitment from the CFO to the company's success.
Industry Context
Granting restricted stock units is a common practice to incentivize and retain key executives in publicly traded companies.
Comparison to Industry Standards
- Many companies in the health and wellness industry, such as Herbalife Nutrition and Nu Skin Enterprises, use similar equity compensation plans for their executives.
- The size of the grant and vesting schedule are generally aligned with industry benchmarks for CFO compensation.
Stakeholder Impact
- Shareholders may view the grant of restricted stock units positively, as it aligns management's interests with long-term company performance.
- Employees may see this as a sign of stability and commitment from the company to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of the transaction: G. Doug Iiekking was granted 29,877 restricted stock units. |
| 03/03/2025 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.